Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2009 02:30 ET | Source: Active Biotech

Ny information kring RhuDex(TM)

RhuDex har undersökts i en serie laboratorietester under det brittiska läkemedelsverkets (Medicines and Healthcare products Regulatory Agency) översyn för att utesluta att det finns några...
August 07, 2009 02:30 ET | Source: Active Biotech

New information regarding RhuDex(TM)

In cooperation with the British drug regulatory authority MHRA (Medicines and Healthcare Products Regulatory Agency), MediGene has conducted a series of in-vitro studies to rule out any potential...
August 06, 2009 02:30 ET | Source: Active Biotech

Active Biotech AB Delårsrapport januari-juni 2009

För ytterligare information, vänligen kontakta: Tomas LeandersonVDTfn 046-19 20 95 Göran...
August 06, 2009 02:30 ET | Source: Active Biotech

Active Biotech AB Interim report January-June 2009

For further information, please contact: Tomas LeandersonPresident and CEOTel: +46 (0)46-19 20 95 Göran...
July 28, 2009 02:30 ET | Source: Active Biotech

Active Biotech's Cancer Project ANYARA Featured in Journal of Clinical Oncology

Two parallel Phase I studies1) were performed, one monotherapy study (including 39 patients with non-small cell lung cancer (NSCLC), pancreatic cancer (PC) or renal cell cancer (RCC)) with ANYARA and...
July 28, 2009 02:30 ET | Source: Active Biotech

Active Biotechs cancerprojekt ANYARA presenteras i Journal of Clinical Oncology

Två parallella kliniska fas I-studier1) har genomförts, en monoterapistudie med ANYARA enbart (omfattande 39 patienter med icke-småcellig lungcancer (NSCLC), bukspottkörtelcancer (PC) eller njurcancer...
June 30, 2009 02:30 ET | Source: Active Biotech

Antal aktier och röster i Active Biotech

Idag, den sista handelsdagen i månaden, finns totalt 64 052 238 aktier och röster i bolaget. Lund den 30 juni 2009 Active Biotech AB (publ) För...
June 30, 2009 02:30 ET | Source: Active Biotech

Number of shares and votes in Active Biotech

Today, the last trading day of the month, there are in total 64,052,238 shares and votes in Active Biotech. Lund, June 30, 2009 Active Biotech AB (publ) For further...
June 25, 2009 08:00 ET | Source: Active Biotech

Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trial

Jerusalem, Israel and Lund, Sweden, June 25, 2009 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced completion of patient enrollment for...
June 25, 2009 08:00 ET | Source: Active Biotech

BRAVO-studien för laquinimod fullrekryterad

Lund och Jerusalem, Israel den 25 juni, 2009 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) och Active Biotech (NASDAQ OMX NORDIC: ACTI) meddelar idag att den andra registreringsgrundande...